Wright Profemur Hip Settlement Reached Days Before Trial Set To Begin

|

Just days before trial was scheduled to begin, an agreement has been reached to settle a Wright hip replacement lawsuit filed by a man who alleged that a Profemur hip implant failed after just four years. 

The settlement was disclosed in a court order (PDF) issued by U.S. District Court Judge Yvonne Gonzalez Rogers on March 20, involving a product liability lawsuit brought by Gregory Tucker against Wright Medical Technology, Inc.

Before the agreement was reached, trial was scheduled to begin in the case on April 1, in the U.S. District Court for the Northern District of California.

"*" indicates required fields

"*" indicates required fields

Tucker filed the hip replacement lawsuit in May 2011, alleging that he experienced problems with a Wright Profemur Hip System that was implanted in his right hip in March 2006. On May 7, 2010, Tucker’s hip implant fractured, resulting in the need for revision surgery to remove the Profemur hip and replace it with another device.

The settlement was reported just one day after Judge Rogers issued another order (PDF), denying an attempt by Wright Medical to have the case dismissed. While Judge Rogers granted Wright Medical’s Motion for Summary Judgment as to claims for strict liability based on design defect, manufacturing defect and failure to warn, as well as negligence claims for failure to warn, the case was allowed to proceed under claims for negligence based on design defect.

Unlike traditional hip replacement systems, which feature a single femoral component, the Wright Profemur hip features two modular pieces that allow the implant to be adjusted for leg length. However, Tucker alleged that the design was prone to fret, corrode and fatigue around the modular junction as the metal parts rub against each other.

A number of other Wright Profemur hip lawsuits have been filed in courts throughout the country by individuals who experienced similar problems, and this trial was going to be closely watched by product liability lawyers involved in the litigation, as it may have gauged how juries would respond to similar evidence and testimony that would be offered throughout other cases.

Details of the Wright Profemur hip settlement reached in the Tucker case were not disclosed by the court.

In August, Wright Medical filed a report with the Securities and Exchange Commission (SEC) providing updated information about the pending product liability lawsuits over the Profemur modular hip, estimating that their liability may be between $24 million and $39 million for cases brought by individuals in North America who required a revision surgery following the fracture of a long Profemur titanium modular neck, or who may require revision in the future.  The company has estimated that they will pay the majority of any settlements for Wright Profemur fractures within the next four years.


0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.
Dupixent users are coming forward with accounts of devastating cancer diagnoses, saying the popular eczema drug masked early warning signs of cutaneous T-cell lymphoma. As the FDA investigates and the first lawsuit is filed, researchers warn Dupixent may unmask or accelerate hidden cancers, raising urgent questions about its long-term safety.
Plaintiffs involved in GLP-1 vision loss lawsuits are calling for the litigation to be consolidated in New Jersey federal court, and not be bundled with existing stomach paralysis litigation.